These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23371256)

  • 1. [Personalized therapy].
    Hallek M; Wolf J
    Internist (Berl); 2013 Feb; 54(2):145-6. PubMed ID: 23371256
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized medicine: the medicine of tomorrow. Foreword.
    Tremblay-Servier M
    Metabolism; 2013 Jan; 62 Suppl 1():S1. PubMed ID: 23018144
    [No Abstract]   [Full Text] [Related]  

  • 3. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From next-generation sequencing to nanopore sequencing technology: paving the way to personalized genomic medicine.
    Ku CS; Roukos DH
    Expert Rev Med Devices; 2013 Jan; 10(1):1-6. PubMed ID: 23278216
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalizing medicine for the child with heart disease: a path forward.
    Mital S
    J Cardiovasc Pharmacol; 2011 Jul; 58(1):1-3. PubMed ID: 21654326
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomics, personalized medicine and cancer practice.
    Dancey J
    Clin Biochem; 2012 Apr; 45(6):379-81. PubMed ID: 22424082
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequencing set to alter clinical landscape.
    Hayden EC
    Nature; 2012 Feb; 482(7385):288. PubMed ID: 22337027
    [No Abstract]   [Full Text] [Related]  

  • 9. Biomarkers and oncology: the path forward to a learning health system.
    Yu PP; Hoffman MA; Hayes DF
    Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
    [No Abstract]   [Full Text] [Related]  

  • 10. [Targeted therapy of a cancer patient is multiprofessional collaboration].
    Ristimäki A; Kytölä S; Haglund C; Bono P
    Duodecim; 2013; 129(10):1071-9. PubMed ID: 23767137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of genomics on personalized cancer medicine.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research impulses for personalized cancer therapies].
    Aktuelle Urol; 2013 Sep; 44(5):349. PubMed ID: 24043531
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research projects for implementation of individualized medicine].
    Lieb W; Grabe HJ; Kroemer HK
    Dtsch Med Wochenschr; 2013 Mar; 138(13):665-6. PubMed ID: 23512371
    [No Abstract]   [Full Text] [Related]  

  • 14. NCI-MATCH launch highlights new trial design in precision-medicine era.
    McNeil C
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446
    [No Abstract]   [Full Text] [Related]  

  • 15. [Personalized medicine 2011].
    Blum HE
    Dtsch Med Wochenschr; 2011 Mar; 136(10):459-60. PubMed ID: 21365521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potential and perspective of genetic testing in Renaissance of laboratory medicine].
    Nobori T
    Rinsho Byori; 2013 Aug; 61(8):693-9. PubMed ID: 24218766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR; Johnson BE; Sledge GW
    Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Personalized therapeutic targeting by exome analysis].
    Lamy A; Angot E; Sabourin JC
    Ann Pathol; 2012 Nov; 32(5 Suppl):S44-5. PubMed ID: 23127937
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress towards personalized medicine.
    Bates S
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine benefits patients in early trials: matching targeted therapies with gene mutations is associated with better outcomes, even in phase 1 studies.
    Printz C
    Cancer; 2012 Oct; 118(20):4911-2. PubMed ID: 23042614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.